Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates

Antimicrob Agents Chemother. 1998 Jan;42(1):190-3. doi: 10.1128/AAC.42.1.190.

Abstract

The sequence of the DNA gyrase gyrA gene of Serratia marcescens ATCC 14756 was determined. An open reading frame of 2,640 nucleotides coding for a polypeptide with a calculated molecular mass of 97,460 was found, and its sequence complemented the sequence of an Escherichia coli gyrA temperature-sensitive mutation. Analysis of the PCR products of the quinolone resistance-determining regions of gyrA genes from six quinolone-resistant clinical isolates revealed a single amino acid substitution, Ser-83 to Arg or Asp-87 to Tyr, in all six mutants, suggesting that a mutational alteration in gyrA is a common mechanism of quinolone resistance in S. marcescens.

MeSH terms

  • 4-Quinolones
  • Amino Acid Sequence
  • Anti-Infective Agents / therapeutic use
  • Base Sequence
  • Cloning, Molecular
  • DNA Gyrase
  • DNA Topoisomerases, Type II / genetics*
  • Drug Resistance, Microbial / genetics
  • Humans
  • Molecular Sequence Data
  • Point Mutation
  • Serratia Infections / drug therapy
  • Serratia Infections / enzymology
  • Serratia Infections / genetics*
  • Serratia marcescens / drug effects
  • Serratia marcescens / enzymology
  • Serratia marcescens / genetics*
  • Topoisomerase II Inhibitors

Substances

  • 4-Quinolones
  • Anti-Infective Agents
  • Topoisomerase II Inhibitors
  • DNA Gyrase
  • DNA Topoisomerases, Type II

Associated data

  • GENBANK/U56906